Delivery Order SPE2DB24D2212-SPE2DB25FHPNF

Award Date 4/16/25
Potential Completion Date 5/7/25
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,173.33, is for the delivery of LONSURF 20 MG-8.19 MG tablets, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order without any set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,124.17, is a Firm Fixed Price Delivery Order for a pharmaceutical product called LONSURF 15 MG-6.14 MG TABLET 40S. The award has an ultimate completion date of February 21, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $10,220.76, is a delivery order for the drug LONSURF 20 MG-8.19 MG TABLET 20S. The contract has an ultimate completion date of March 3, 2025 and is a Firm Fixed Price instrument. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,092.24, is for the delivery of LONSURF 15 MG-6.14 MG tablets. The contract has an ultimate completion date of April 22, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,173.33 firm fixed-price delivery order is for the supply of the medication LONSURF 20 MG-8.19 MG TABLET 60S, with a performance period ending on March 25, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,406.92, is for the delivery of the medication LONSURF 20 MG-8.19 MG TABLET 20S. The contract is a Firm Fixed Price Delivery Order with a completion date of February 6, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $19,198.52 firm fixed price delivery order is for the supply of the pharmaceutical product LONSURF 20 MG-8.19 MG TABLET 60S. This delivery order falls under a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with the DLA to provide a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $9,583.44 under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract covers the delivery of the drug LONSURF 15 MG-6.14 MG TABLET 20S, with a performance period ending on June 12, 2024. The contract is a Firm Fixed Price arrangement and was not designated with any set-aside requirements, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,599.25 firm fixed-price delivery order is for the supply of LONSURF 20 MG-8.19 MG tablets, a specialty medication, with a period of performance through November 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $4,835.01 firm fixed price delivery order is for the supply of 4564118881 - LONSURF 15 MG-6.14 MG TABLET 40S, a pharmaceutical product. The contract has an ultimate completion date of April 19, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery...
  • SPE2DB24D2212
    Indefinite Delivery Contract
  • SPE2DB24D2212-SPE2DB25FHPNF
    Delivery Order

This federal contract award, valued at $10,173.33, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of LONSURF 20 MG-8.19 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of May 7, 2025 and is a firm fixed-price contract.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

The contract award is not designated as a set-aside, indicating open competition. No subcontractors are mentioned in the provided information.

Generated 7/16/25, 12:04 PM